The selective PDE-4 Inhibitor Roflumilast Reduces Body Weight, increased Insulin Sensitivity and reduces the non-alcoholic Fatty Liver Disease in Mice with elevated PKA-dependent activation of Mitochondria
Year: 2015
Type: article
Source: Der Internist
Authors: Florian Kahles, Hannes M. Findeisen, Julia Moellmann, Corinna Lebherz, Ketsia Hess, S. Krueger, Michael Lehrke, Robert Stoehr, Nikolaus Marx, Frank Tacke, Christer Baeck
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2793378373
